treatment options

Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in the Cerebrospinal Fluid of Pediatric Patients With MOG Antibody-Associated Disease: Insights From an Asian Multicenter Cohort

MOG Antibody-Associated Disease Overview Myelin Oligodendrocyte Glycoprotein (MOG) antibodies are increasingly recognized as significant biomarkers in a subset of neurological […]

Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in the Cerebrospinal Fluid of Pediatric Patients With MOG Antibody-Associated Disease: Insights From an Asian Multicenter Cohort Read Post »

Real-world experience with switching from intravenous immunoglobulin to subcutaneous efgartigimod PH20 in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A case series

Study Overview The transition from intravenous immunoglobulin (IVIg) to subcutaneous efgartigimod PH20 in patients diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy

Real-world experience with switching from intravenous immunoglobulin to subcutaneous efgartigimod PH20 in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A case series Read Post »

Scroll to Top